Pediatric Small Bowel Obstruction

Overview

Small-bowel obstruction (SBO)

Small-bowel obstruction in children is caused by either a mechanical lesion that produces a fixed luminal occlusion or by functional dysmotility (Pediatric intestinal pseudo-obstruction, PIPO) that produces obstructive physiology without an anatomic transition point. Presentation ranges from neonatal surgical emergencies to chronic relapsing motility disorders. Rapid recognition of red flags for ischemia and a structured diagnostic approach improve outcomes.

Etiology and classification

High-level categories

Note: PIPO (Pediatric Intestinal Pseudo‑Obstruction) and CIPO (Chronic Intestinal Pseudo‑Obstruction) describe the same pathophysiologic syndrome — clinical and radiographic/physiologic evidence of bowel obstruction without a mechanical lesion — but differ mainly by age of onset and typical context: PIPO presents in infancy or childhood, is more often congenital or genetic (familial visceral myopathies/neuropathies, MMIHS, mitochondrial disorders) and frequently associates with syndromic features such as urologic involvement, malrotation, or other visceral malformations, with greater impact on growth, nutrition, and development and a higher likelihood of severe neonatal presentation and need for long‑term parenteral nutrition; CIPO is the term commonly used across all ages and in adult cohorts, where etiologies more often include long‑standing primary disorders and acquired causes (postinfectious, autoimmune, paraneoplastic, medication‑induced), producing a chronic course with similar overall morbidity but a different comorbidity profile reflecting adult exposures and conditions.

Common mechanical causes by anatomic site

Anatomic site Intrinsic causes Extrinsic causes
Duodenum Duodenal atresia/stenosis; duodenal web; duodenal hematoma; duplication cyst; annular pancreas Ladd bands/malrotation; preduodenal portal vein; vascular compression (SMA/Wilkie syndrome); external mass
Jejunum / ileum Intestinal atresia/stenosis; duplication cyst; intussusception; Crohn strictures; meconium ileus/plug Malrotation with volvulus; adhesions; internal hernia; external compression
Distal small bowel / ileocecal Meckel diverticulum complications; Crohn disease strictures; neoplasm Inguinal/femoral hernia; adhesive bands; closed-loop volvulus
Luminal / general Heavy parasite burden (Ascaris); foreign body Postoperative adhesions; inflammatory or neoplastic external masses

Functional Causes of Small Bowel Obstruction

Visceral myopathies

  1. Primary (disorders of the intestinal smooth muscle)
    1. Familial (primary) visceral myopathies
      • Classic familial clinical categories (historically grouped into four types)
      • Recognized genetic causes (examples): ACTG2, MYH11, ACTA2, and visceral involvement with FLNA
    2. Sporadic infantile or childhood visceral myopathy
    3. African degenerative leiomyopathy
    4. Megacystis‑microcolon‑intestinal hypoperistalsis syndrome (MMIHS)
    5. Mitochondrial neurogastrointestinal encephalopathy (MNGIE) and other primary mitochondrial disorders affecting smooth muscle
    6. Other rare congenital/developmental smooth‑muscle disorders (cytoskeletal or contractile protein defects)
  2. Secondary (systemic disease involving the intestinal smooth muscle)
    1. Connective tissue and autoimmune diseases
      • Dermatomyositis; polymyositis
      • Systemic lupus erythematosus
      • Mixed connective tissue disease
      • Scleroderma (systemic sclerosis)
      • Vascular Ehlers‑Danlos syndrome (type IV)
    2. Primary muscle disorders / muscular dystrophies
      • Myotonic dystrophy
      • Duchenne and Becker muscular dystrophies
      • Desmin myopathy and other myofibrillar myopathies
      • Mitochondrial myopathies overlapping with primary mitochondrial disorders
    3. Infiltrative and inflammatory processes
      • Amyloidosis (systemic)
      • Brown bowel syndrome (ceroid/lipofuscin deposition)
      • Autoimmune or idiopathic leiomyositis
      • Granulomatous infiltration (rare)
    4. Ischemic or vascular injury (eg, in utero vascular accidents leading to atresia and secondary muscle loss)
    5. Toxin and medication-related myopathy
      • Chronic opioid exposure with smooth muscle dysfunction
      • Certain chemotherapeutics and toxins causing visceral smooth muscle injury
    6. Endocrine and metabolic contributors (eg, severe electrolyte disturbances, malnutrition)

Visceral neuropathies

  1. Primary (disorders of the enteric nervous system)
    1. Familial visceral neuropathies (heritable enteric neuropathies)
    2. Sporadic visceral neuropathies (hyperganglionosis, hypoganglionosis)
    3. Ganglioneuromatosis (including association with MEN2B)
    4. Sporadic and familial aganglionosis (Hirschsprung disease and long‑segment variants)
    5. Disorders of the interstitial cells of Cajal (reduced density, abnormal morphology, delayed maturation)
    6. Isolated neuronal dysplasia and other congenital neuronal malformations
    7. Unclassified or idiopathic enteric neuropathies (including combined neuropathy/myopathy phenotypes)
  2. Secondary (systemic diagnoses affecting the enteric nervous system)
    1. Central or peripheral neural disease
      • Familial dysautonomia (Riley‑Day syndrome)
      • Diabetic autonomic neuropathy (rare in pediatrics)
      • MNGIE (mitochondrial disorder with neuropathic features)
      • Neurodegenerative conditions with autonomic involvement (rare pediatric examples)
    2. Infectious and postinfectious causes
      • Chagas disease (Trypanosoma cruzi)
      • Postviral enteric neuropathy: CMV, VZV, HSV‑1, EBV, rotavirus, adenovirus, HIV
      • Bacterial or other infections causing ENS injury (rare)
      • Lyme disease (Borrelia) associated neuropathy (reported)
      • Postinfectious autoimmune neuropathies
    3. Toxic and medication-induced neuropathies
      • Vinca alkaloids (vincristine, vinblastine) and other neurotoxic chemotherapies
      • Chronic opioids and anticholinergics
      • Some antiepileptics and antipsychotics
      • Calcium‑channel blockers; chronic macrolide exposure (prokinetic/paradoxical effects)
      • Environmental toxins and in‑utero exposures (eg, fetal alcohol syndrome)
      • Marine envenomations (rare)
    4. Radiation enteritis causing ENS and muscular injury
    5. Autoimmune and paraneoplastic enteric neuropathies
      • Autoimmune gut dysmotility (AAG) with neural antibodies (eg, anti‑Hu/ANNA‑1)
      • Celiac disease associated neuropathy and eosinophilic gastroenteritis
      • Paraneoplastic syndromes associated with thymoma, neuroendocrine tumors, and small‑cell malignancies
    6. Endocrine and metabolic causes
      • Electrolyte disturbances (hypokalemia, hyponatremia, hypocalcemia)
      • Uremia and renal failure–associated neuropathy
      • Thyroid disease (severe hypothyroidism)
      • Porphyria (autonomic dysfunction during attacks)
      • Carnitine deficiency, vitamin E deficiency, and other metabolic disorders
    7. Tumor-associated and chemotherapy-related neuropathies
      • Neural crest tumors (neuroblastoma, ganglioneuroma) with local ENS involvement
      • Paraneoplastic autoimmune syndromes (anti‑Hu, anti‑CRMP5)
      • Chemotherapy‑induced neuropathy (vinca alkaloids, platinum agents in some cases)
    8. Miscellaneous and functional contributors
      • Ogilvie syndrome (acute colonic pseudo‑obstruction) and overlap syndromes
      • Crohn disease and severe inflammatory bowel disease causing secondary neuronal injury
      • Angioedema causing transient obstruction features
      • Severe eating disorders (anorexia nervosa, bulimia) with autonomic dysfunction
      • Small intestinal bacterial overgrowth (SIBO) as contributor and consequence of dysmotility
      • Iatrogenic nerve injury after surgery (rare localized neuropathy)
Practical diagnostic and testing considerations
  • Genetic testing: consider panels including ACTG2, MYH11, ACTA2, FLNA and mitochondrial testing where clinically indicated.
  • Full‑thickness intestinal biopsy: combined histology and immunohistochemistry (neuronal markers, smooth‑muscle markers, ICC markers such as c‑kit/CD117 and Ano1) and, if available, electron microscopy to distinguish myopathic vs neuropathic etiologies.
  • Small‑bowel manometry and autonomic testing: helpful to phenotype motility disorders and identify myopathic versus neuropathic patterns.
  • Targeted workup for secondary causes: infectious serologies, paraneoplastic antibody panels (eg, anti‑Hu), endocrine and

Pathophysiology and clinical consequences

Obstruction increases intraluminal pressure causing venous congestion, bowel wall edema, lymphatic obstruction and third-spacing into the lumen. These changes lead to hypovolemia, bacterial overgrowth, mucosal ischemia and, if strangulation occurs, necrosis and perforation. Functional obstruction produces stasis, malabsorption, bacterial overgrowth, and chronic dilatation without a discrete transition point.

Presentation and diagnostic approach

Key principle

Age, timing, prior operations, and specific symptoms (bilious versus nonbilious vomiting, abdominal distention, colicky pain, obstipation) are central to differential diagnosis and urgency.

Age-specific features

Age group Typical presentation and common mechanical etiologies
Fetus / Neonate Maternal polyhydramnios; neonatal bilious vomiting; failure to pass meconium in 24–48 h. Common causes: duodenal/jejunal/ileal atresia, malrotation with midgut volvulus, meconium ileus, gastroschisis-associated atresia.
Infant (weeks to months) Projective nonbilious vomiting (hypertrophic pyloric stenosis 2–8 wk); intussusception (colicky pain, “currant jelly” stools); delayed presentation of congenital obstructions. Consider congenital and acquired causes.
Toddlers / Children Intussusception (peaks in infancy/early childhood); hernias causing incarceration; adhesive SBO after prior surgery; neoplasm; parasitic luminal obstruction in endemic exposure.
Adolescents Adhesions from prior surgery; Crohn disease strictures; internal hernias; neoplasm; functional causes may present as chronic/recurrent obstruction (PIPO).

Initial priorities and tests

  1. Resuscitation: ABCs, rapid IV isotonic fluids, correct electrolytes, monitor perfusion.
  2. Decompression: large-bore nasogastric tube when vomiting or risk of aspiration.
  3. Imaging:
  4. Laboratory tests: CBC, electrolytes, lactate, blood gas and inflammatory markers; rising lactate or leukocytosis increase concern for ischemia.
  5. Specialized testing: small-bowel manometry and full-thickness biopsy with immunohistochemistry for chronic/recurrent obstruction when mechanical causes are excluded.
Clinical pearls: Neonatal bilious vomiting is a surgical emergency until malrotation with volvulus is excluded. Presence of distal colonic gas on radiograph suggests partial obstruction. Emesis that is bilious usually indicates proximal small-bowel obstruction.

Imaging findings that raise concern for ischemia or require urgent surgery

Management principles

Initial stabilization

Nonoperative management

Operative management

Management of functional obstruction (PIPO)

Discharge planning and follow-up

Concise differential table by age group

Age group Top mechanical etiologies Top functional/other etiologies
Fetus / Neonate Duodenal atresia; jejunal/ileal atresia; malrotation with volvulus; meconium ileus; gastroschisis-associated atresia Congenital PIPO (rare); cystic fibrosis presenting with meconium ileus; vascular accidents in utero
Infant (weeks to months) Pyloric stenosis; intussusception; congenital atresia presenting later; duplication cyst Postinfectious enteric neuropathy; early presentation of visceral myopathy
Toddlers / Young children Intussusception; incarcerated inguinal hernia; congenital bands; adhesions after surgery Postinfectious dysmotility; developing Crohn disease (rare in toddlers)
Children / Adolescents Adhesive obstruction (prior surgery); Crohn disease strictures; internal hernia; neoplasm; volvulus PIPO (chronic presentations); medication-induced dysmotility; systemic diseases affecting ENS or muscle

Key practice points


Updated table from NASPGHAN Fellow review:

Comparison Table: Neonates vs Children/Adolescents — SBO

Signs, exam, radiograph and CT findings across partial/complete obstruction and strangulation

Category Partial or Complete Obstruction
Neonates		 Partial or Complete Obstruction
Children & Adolescents		 Strangulation Obstruction
Signs and symptoms Maternal polyhydramnios Abdominal distension Vomiting (often bilious) Failure to pass meconium within 24–48 hrs Colicky abdominal pain Currant-jelly stools (intussusception) Abdominal distension Nausea/vomiting; obstipation Constant severe abdominal pain Hematochezia (≈15% with volvulus) Peritoneal signs, fever Tachycardia, leukocytosis, acidosis
Physical examination Hyperactive bowel sounds early Abdominal tenderness Palpable abdominal mass (intussusception, volvulus) Hyperactive bowel sounds early Abdominal tenderness Painful/palpable mass (intussusception/volvulus) Absent bowel sounds if ileus or late obstruction Marked tenderness or rigidity Peritonitis signs Absent or severely diminished bowel sounds Systemic toxicity
X‑ray findings Distended loops of small bowel Multiple air‑fluid levels Paucity of colonic gas in complete obstruction Distended small-bowel loops Air‑fluid levels Presence of colonic gas suggests partial obstruction Pneumoperitoneum if perforation Markedly asymmetric dilation or gas‑less distal bowel Radiographic closed‑loop features
CT scan findings Fluid‑filled loops proximal to obstruction Localized transition zone Collapsed distal small bowel/colon Bowel wall thickening (possible) Proximal fluid‑filled loops and transition point Collapsed distal bowel Target sign with intussusception Serrated "beak" at transition Pneumatosis intestinalis Portal venous gas Mesenteric haziness/stranding Absent or decreased bowel wall enhancement with IV contrast
Notes
  • Bowel distension is more prominent with distal (ileal) obstruction.
  • Emesis is usually bilious and more prominent with proximal (jejunal/duodenal) obstruction.
  • Passage of stool early in obstruction can occur from peristalsis distal to the blockage; continued passage of gas or stool >6–12 hours after onset suggests partial obstruction.
```
References:

Kliegman, R. M., Stanton, B. F., St Geme, J. W., Schor, N. F., & Behrman, R. E. (Eds.). (2020). Nelson Textbook of Pediatrics (21st ed.). Elsevier.

Coran, A. G., Adzick, N. S., Krummel, T. M., Laberge, J.-M., Shamberger, R. C., Caldamone, A. A., ... & Holcomb, G. W. (Eds.). (2012). Pediatric Surgery (7th ed.). Elsevier.

Grosfeld, J. L., O'Neill, J. A., Coran, A. G., & Fonkalsrud, E. W. (Eds.). (2018). Pediatric Surgery (2nd ed.). Wolters Kluwer.

Di Lorenzo, C., & Nurko, S. (2008). Chronic intestinal pseudo-obstruction in children: Clinical features, diagnosis, and management. Journal of Pediatric Gastroenterology and Nutrition, 46(Suppl 1), S3–S11.

Waseem, M., & Simon, H. K. (2010). Bilious vomiting in the neonate: A surgical emergency. Pediatric Emergency Care, 26(9), 687–691.

Bergman, S. A., & Kliegman, R. M. (2015). Intestinal atresia and stenosis. In R. M. Kliegman, B. F. Stanton, J. W. St Geme, N. F. Schor, & R. E. Behrman (Eds.), Nelson Textbook of Pediatrics (21st ed., pp. 1156–1164). Elsevier.

Kiasatdolatabadi, A., Dehghani, S. M., & Murad, M. H. (2022). Management of adhesive small bowel obstruction in children: A systematic review. Journal of Pediatric Surgery, 57(6), 1100–1110.

Blakelock, R., & Hall, N. J. (2017). Gastroschisis and jejunoileal atresia: Pathogenesis and management. Pediatric Surgery International, 33(9), 1015–1024.

Alvarado, A. (2019). Intussusception in children: Current concepts and management. Pediatric Clinics of North America, 66(2), 457–470.

Stringer, M. D., & Aylin, P. (2016). Meconium ileus and cystic fibrosis: Diagnosis and management. Archives of Disease in Childhood, 101(6), 588–593.

Wagner, B. J., & Zinner, M. J. (2018). Midgut malrotation and volvulus: Clinical presentation and diagnosis. Clinics in Colon and Rectal Surgery, 31(4), 250–257.

Linden, A. F., Raiji, M. T., Kohler, J. E., St Peter, S. D., & Garber, M. R. (2021). Evaluation of a water-soluble contrast protocol for nonoperative management of pediatric adhesive small bowel obstruction. Journal of Pediatric Surgery, 56(7), 1234–1240.

Drossman, D. A., Hasler, W. L., & Bell, R. (2016). Rome IV—Disorders of gut-brain interaction: Chronic intestinal pseudo-obstruction. Gastroenterology, 150(6), 1402–1414.

Di Lorenzo, C., & Venkatesan, T. (2015). Pediatric intestinal motility disorders: A practical approach. Journal of Pediatric Gastroenterology and Nutrition, 60(2), 175–184.

Sarnacki, S., Serinet, M. O., Riviere, J. B., & Laberge, J.-M. (2019). Megacystis-microcolon-intestinal hypoperistalsis syndrome: Clinical spectrum and outcomes. Journal of Pediatric Surgery, 54(4), 715–722.

Molinari, C., & Carchiolo, M. (2018). Superior mesenteric artery (Wilkie) syndrome in children: Diagnosis and surgical options. Pediatric Surgery International, 34(3), 329–337.

Pini Prato, A., Corcione, F., & Patricio, A. (2017). Role of ultrasound in the diagnosis of pediatric small bowel obstruction. Ultrasound in Medicine & Biology, 43(12), 2629–2638.

American Academy of Pediatrics. (2024). Gastrointestinal obstruction. Pediatric Care Online. https://publications.aap.org/pediatriccare/article/doi/10.1542/aap.ppcqr.396166/1587/Gastrointestinal-Obstruction

ESPEN/ESPGHAN Working Group. (2018). Consensus guidelines for the diagnosis and management of chronic intestinal pseudo-obstruction in children. Journal of Pediatric Gastroenterology and Nutrition, 67(4), 495–507.

Pillai, A., Kiely, E., & De Coppi, P. (2019). Surgical management and outcomes of pediatric small bowel volvulus. European Journal of Pediatric Surgery, 29(5), 445–452.

Sims, H., & Waguespack, A. (2014). Management of hypertrophic pyloric stenosis: Evidence-based updates. Pediatric Surgery International, 30(2), 103–110.

Mane, S., Tomko, D., & Frischer, J. (2020). Role of small-bowel manometry and full-thickness biopsy in pediatric intestinal pseudo-obstruction. Neurogastroenterology and Motility, 32(10), e13972.